Bliss GVS Pharma Limited Financial Ratios
BLISSGVS · Healthcare · Current price ₹654.85
P/E ratio
53.5x
P/B ratio
6.3x
ROE
10.8%
ROCE
16.6%
Debt / Equity
0.02
Dividend yield
0.2%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 53.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 6.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 10.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 16.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.02 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Bliss GVS Pharma Limited's latest numbers.
Bliss GVS Pharma Limited profitability
Bliss GVS Pharma Limited generates a return on equity of 10.8% and a return on capital employed of 16.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.02 and a P/E of 53.5x, Bliss GVS Pharma Limited is conservatively financed. Our overall business-quality score for the company is 4.6 / 10.
Understand the ratios
More on Bliss GVS Pharma Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.